Clinical trials constitute a major portion of cost spent on drug development and approval. ReSurfX solutions help identify sensitive variations that current technologies and processes miss.
ReSurfX in addition, our novel way of identifying variations on studied outcomes and early detection of adverse effects can save significant effort spent on these processes. Our remarkable and unique ability to predict outcomes ahead of most other solutions while integrating with your experts and workflow brings you unprecedented value to your enterprise goals and market value in this expensive and often unpredictable phase of drug development. Our applications enhance many applications in safety as well as efficacy (two major facets of clinical trials).
As with many other aspects, our solution integrates with your expertise and processes in place, in some instances replacing certain steps and in other instances improving your data and analytics based processes.